LambdaVision
Biomaterials · Regenerative Medicine
Lately:2 news stories in 90 daysFollow changes →
Facts
as of Nov 17, 2026About LambdaVision LEADERSHIP Partners Investors LambdaVision is leveraging space to develop an innovative, protein-based artificial retina that utilizes a light-activated protein, bacteriorhodopsin, to restore functional sight to those who would otherwise be blind due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP).
- Headquarters
- Farmington, United States
- Employees
- 51-200estimated range
- Website
- lambdavision.com
These are the key facts about LambdaVision on Alion as of Nov 17, 2026. LambdaVision is headquartered in Farmington, United States. The latest round is Seed of $7M, announced in 2025.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Farmington United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$7MTotal raised
$2.8MPublic grants6 public grants
SeedLatest round
8Rounds and grants
Money by yearUSD, rounds and grants
Sources: funding announcements, grant and company registers
Milestones
May 18
Nov 6, 2025
Raised a round Seed $7M · led by Seven Seven Six · Pulse 2.0
Jul 12, 2024
Won a grant $900k · CORDIS
Each milestone is dated by its source: registers, filings, the press
Newsroom
top 5%Web presenceof 133.2M domains by links, Common Crawl
Sep 12026
News · YahooFinance
WOODBRIDGE, Conn., September 01, 2026--LambdaVision, a pre-clinical-stage biotech advancing on-Earth and microgravity bioprocesses, today announced an upcoming mission with Helog…
Jun 242026
May 182026
News · YahooFinance
WOODBRIDGE, Conn., May 18, 2026--LambdaVision, a pre-clinical-stage biotech advancing on-Earth and microgravity bioprocesses, today announced a strategic partnership with Helogen…
Feb 242026
Feb 242026
News · markets.ft.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Nov 6, 20252025
News · Pulse 2.0
LambdaVision, a biotechnology company developing a protein-based artificial retina to restore vision for patients affected by retinal degenerative diseases, announced it has rais…
Sources: the outlets named on each headline, each story once
